234 related articles for article (PubMed ID: 26164942)
1. [Analyses of Binding Profiles of the GII. 12 Norovirus with Human Histo-blood Group Antigens].
Jin M; Chen K; Song J; Li H; Zhang Q; Kong X; Liu N; Duan Z
Bing Du Xue Bao; 2015 Mar; 31(2):164-9. PubMed ID: 26164942
[TBL] [Abstract][Full Text] [Related]
2. Strain-specific interaction of a GII.10 Norovirus with HBGAs.
Jin M; Tan M; Xia M; Wei C; Huang P; Wang L; Zhong W; Duan Z; Jiang X
Virology; 2015 Feb; 476():386-394. PubMed ID: 25591173
[TBL] [Abstract][Full Text] [Related]
3. [The preparation of P particle of the norovirus strain SZ9711 from China and its affinity analysis with human histo-blood group antigens in saliva].
Jin M; He YQ; Li HY; Yang H; Zhang HL; Qi R; Yang XK; Fang SS; Tan M; Duan ZJ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):5-7. PubMed ID: 20848836
[TBL] [Abstract][Full Text] [Related]
4. Chimeric GII.3/GII.6 norovirus capsid (VP1) proteins: characterization by electron microscopy, trypsin sensitivity and binding to histo-blood group antigens.
Ma S; Zheng L; Liu J; Wang W; Ma J; Cheng X; Ge L; Wang M; Huo Y; Shen S
Arch Virol; 2018 Dec; 163(12):3265-3273. PubMed ID: 30143876
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic cleavage promotes disassembly of GII.3 norovirus virus like particles and its binding to salivary histo-blood group antigens.
Huo Y; Wang W; Zheng L; Chen X; Shen S; Wang M
Virus Res; 2017 Aug; 240():18-24. PubMed ID: 28754559
[TBL] [Abstract][Full Text] [Related]
6. Expression and characterization of the major capsid protein derived from a GII.6 norovirus strain isolated in China.
Huo Y; Zheng L; Chen X; Ge L; Wang Y
Microb Pathog; 2017 Apr; 105():131-137. PubMed ID: 28219831
[TBL] [Abstract][Full Text] [Related]
7. Functional and structural characterization of Norovirus GII.6 in recognizing histo-blood group antigens.
Cong X; Li HB; Sun XM; Qi JX; Zhang Q; Duan ZJ; Xu Y; Liu WL
Virol Sin; 2023 Feb; 38(1):56-65. PubMed ID: 36216242
[TBL] [Abstract][Full Text] [Related]
8. Relationship between GII.3 norovirus infections and blood group antigens in young children in Tunisia.
Ayouni S; Estienney M; Sdiri-Loulizi K; Ambert-Balay K; de Rougemont A; Aho S; Hammami S; Aouni M; Guédiche MN; Pothier P; Belliot G
Clin Microbiol Infect; 2015 Sep; 21(9):874.e1-8. PubMed ID: 26003283
[TBL] [Abstract][Full Text] [Related]
9. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.
Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y
Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750
[TBL] [Abstract][Full Text] [Related]
10. Human norovirus inhibition by a human milk oligosaccharide.
Koromyslova A; Tripathi S; Morozov V; Schroten H; Hansman GS
Virology; 2017 Aug; 508():81-89. PubMed ID: 28505592
[TBL] [Abstract][Full Text] [Related]
11. Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens.
de Rougemont A; Ruvoen-Clouet N; Simon B; Estienney M; Elie-Caille C; Aho S; Pothier P; Le Pendu J; Boireau W; Belliot G
J Virol; 2011 May; 85(9):4057-70. PubMed ID: 21345963
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of a household norovirus outbreak occurred in Valencia (Spain).
Carmona-Vicente N; Fernández-Jiménez M; Vila-Vicent S; Rodríguez-Díaz J; Buesa J
BMC Infect Dis; 2016 Mar; 16():124. PubMed ID: 26968797
[TBL] [Abstract][Full Text] [Related]
13. Characterization of virus-like particles derived from a GII.3 norovirus strain distantly related with current dominating strains.
Huo Y; Chen X; Zheng L; Huo J; Zhang S; Wang M; Wang Y
Virus Genes; 2016 Oct; 52(5):613-9. PubMed ID: 27234312
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the new GII.17 norovirus variant that emerged recently as the predominant strain in China.
Jin M; Zhou YK; Xie HP; Fu JG; He YQ; Zhang S; Jing HB; Kong XY; Sun XM; Li HY; Zhang Q; Li K; Zhang YJ; Zhou DQ; Xing WJ; Liao QH; Liu N; Yu HJ; Jiang X; Tan M; Duan ZJ
J Gen Virol; 2016 Oct; 97(10):2620-2632. PubMed ID: 27543110
[TBL] [Abstract][Full Text] [Related]
15. Genetic susceptibility to symptomatic norovirus infection in Nicaragua.
Bucardo F; Kindberg E; Paniagua M; Grahn A; Larson G; Vildevall M; Svensson L
J Med Virol; 2009 Apr; 81(4):728-35. PubMed ID: 19235844
[TBL] [Abstract][Full Text] [Related]
16. Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection.
Tan M; Jin M; Xie H; Duan Z; Jiang X; Fang Z
J Med Virol; 2008 Jul; 80(7):1296-301. PubMed ID: 18461617
[TBL] [Abstract][Full Text] [Related]
17. Phylogenetic and biological characterizations of a GI.3 norovirus.
Zheng L; Zhang H; Ma J; Liu J; Ma S; Wang M; Huo Y
Infect Genet Evol; 2020 Nov; 85():104554. PubMed ID: 32927119
[TBL] [Abstract][Full Text] [Related]
18. Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding.
Shirato H; Ogawa S; Ito H; Sato T; Kameyama A; Narimatsu H; Xiaofan Z; Miyamura T; Wakita T; Ishii K; Takeda N
J Virol; 2008 Nov; 82(21):10756-67. PubMed ID: 18701592
[TBL] [Abstract][Full Text] [Related]
19. Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses.
Shanker S; Czako R; Sankaran B; Atmar RL; Estes MK; Prasad BV
J Virol; 2014 Jun; 88(11):6168-80. PubMed ID: 24648450
[TBL] [Abstract][Full Text] [Related]
20. Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008.
Yang Y; Xia M; Tan M; Huang P; Zhong W; Pang XL; Lee BE; Meller J; Wang T; Jiang X
J Virol; 2010 Sep; 84(18):9595-607. PubMed ID: 20592096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
